文献速递甲状腺疾病

男性分化型甲状腺癌复发风险独立于分期高于女性

Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at Presentation.
PubMed 文献 · Thyroid · 2019-11-13

加拿大CANNECT注册研究纳入2595例2000-2010年诊断的分化型甲状腺癌患者,比较男女复发风险并按AJCC分期分层。男性复发率8.5%高于女性2.2%,校正AJCC或TNM分期后男性复发风险仍显著增高。

要点

  • 男性DTC患者复发率8.5%,女性2.2%。
  • 校正AJCC分期后男性复发风险aHR 2.72。
  • 校正TNM分期后男性复发风险aHR 2.31。

核心结论

  • 男性分化型甲状腺癌复发风险高于女性,且独立于诊断时分期。
  • 男性就诊时分期更晚,但校正分期后复发风险差异仍存在。

研究设计与样本

  • 加拿大甲状腺癌协作注册研究(CANNECT),纳入2000-2010年诊断、年龄≥18岁的分化型甲状腺癌患者2595例。
  • 女性2067例(79.7%),男性528例(20.3%)。

主要发现

  • 男性AJCC分期、T分期、N分期更晚(p<0.001),M分期也更晚(p=0.002)。
  • 男女随访时间无差异:女性7.7±4.0年,男性7.7±4.0年(p=0.985)。
  • 总复发率女性2.2%(n=46),男性8.5%(n=45),p<0.001。
  • 校正AJCC分期后男性复发风险aHR 2.72(95%CI 1.78-4.20),p<0.001。
  • 校正TNM分期后男性复发风险aHR 2.31(95%CI 1.48-3.60),p<0.001。

临床怎么用

  • 男性DTC患者即使诊断分期较早,也应警惕更高复发风险。
  • 是否依据性别调整随访强度和时长尚需进一步研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Well-differentiated thyroid cancer (DTC) presents at a more advanced stage in men than in women, and the mortality in men is higher than that in women. However, it is not clear whether DTC recurrence is affected by sex independent of stage at presentation. The objective of the present study was to assess if male sex is an independent risk factor for recurrence of DTC. Methods: The Canadian Collaborative Network for Cancer of the Thyroid (CANNECT) is a collaborative registry to describe patterns of care for thyroid cancer. We included patients from the CANNECT registry with DTC diagnosed at age 18 or older between 2000 and 2010. We compared men and women with respect to presentation, management, and recurrence risk, stratified for American Joint Committee on Cancer (AJCC) stage. Results: We included 2595 patients, 2067 (79.7%) women and 528 (20.3%) men. Men presented with more advanced AJCC stage (p < 0.001), T stage (p < 0.001), N stage (p < 0.001), and M stage (p = 0.002) There was no difference in follow-up duration between women (7.7 ± 4.0 [mean ± standard deviation] years) and men (7.7 ± 4.0 years, p = 0.985). Overall recurrence was 2.2% (n = 46) for women and 8.5% (n = 45) for men (p < 0.001). In multivariate analysis adjusted for AJCC stage, men were at significantly greater risk for DTC recurrence than women (adjusted hazard ratio 2.72 [95% confidence interval [CI] 1.78-4.20]; p < 0.001). In multivariate analysis adjusted for tumor-node-metastasis (TNM) stage, men were at significantly greater risk for DTC recurrence than women (adjusted hazard ratio 2.31 [CI 1.48-3.60]; p < 0.001). Conclusions: Our study confirms that the risk for recurrence of DTC is higher in men than in women. Although men tend to present with more advanced-stage disease, the difference in recurrence risk persists when adjusted for stage of presentation. It needs to be determined whether sex should influence follow-up intensity and/or duration.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Zahedi A, Bondaz L, Rajaraman M, et al. Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at Presentation. Thyroid. 2019. PMID: 31524071. doi:10.1089/thy.2018.0775

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。